An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · CV Sciences, Inc.
VERDICT
The label
Distribution
read at $0.02
CV Sciences, Inc. holds its Distribution at $0.02.
PHPhase · the trend structure carries the Distribution label
INInsiders · no filings inside 60 days, left as found
POPositioning · no disclosures inside 60 days, left as found
OPOptions · no verdict drawn today, left as found
SCScreen · does not pass the values gate
edge confirmed
edge broken
edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
INVESTOR
The investor read · the season, not the day
As held on the ledger · 2026-06-14
Phase
Distribution · caution
Quantitative state
The statistical read favours the buyers, held for 1 days
Price
$0.02
Valuation
N/A trailing · -0.50 forward price to earnings
Values screen
FAIL· score 70.0
Beta
N/A
OPPORTUNITY
The opportunity · what the numbers say it is worth
Our framework reads AVOID
Read at
$0.02
N/A P/E · -0.50 fwd
Price history & projections · where it has been, where the models see it going
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
SCREEN
The values screen, explained · five checks, plain English
Does not pass. Debt ratio
Business activityIts core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending.Pass
Debt loadInterest-bearing debt is 35.0% of its assets, above the one-third ceiling the screen allows.Fail
Interest-bearing cashCash held in interest-bearing accounts and securities is 4.9% of assets, under the one-third limit.Pass
ReceivablesMoney owed to the company is 0.0% of assets, under the 49% limit.Pass
Revenue purityOnly 0.0% of revenue comes from non-compliant sources — under the 5% line.Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
PLAIN
The business, in plain words · what the numbers mean
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; as a drug manufacturers - specialty & generic name, trial and regulatory outcomes can move it sharply either way.
Plain-English interpretation of our own screen data. Analysis, not advice.
TRADE
Where & how to trade · wherever in the world you are
CVSI trades on OQB. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
TRADER
The trader read · the latest dated commentary
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 29%. Entered 2026-07-25 · Markdown
JOURNAL
The dated journal · newest first, never edited
2026-07-25Markdown$0.02+0.0%Entry 4
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 29%.
2026-07-18Markdown$0.02+0.0%Entry 3
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 29%.
2026-07-03Markdown$0.02+0.0%Entry 2
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Markdown$0.02Entry 1
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
RETURNS
What holding actually paid · price plus dividends
If $1,000 had been placed · historical, not a promise
Period
Price then
Price return
Divs per share
$1,000 became
Total return
1 month
$0.03
-7.7%
·
$923
-7.7%
2 months
$0.04
-30.8%
·
$693
-30.8%
3 months
$0.04
-30.8%
·
$693
-30.8%
6 months
$0.03
-7.7%
·
$923
-7.7%
1 year
$0.03
-7.7%
·
$923
-7.7%
2 years
$0.09
-69.2%
·
$308
-69.2%
3 years
$0.05
-44.6%
·
$554
-44.6%
5 years
$0.44
-93.7%
·
$63
-93.7%
Historical returns from market close data. Past performance does not guarantee future results.
SEALED
This entry now belongs to the ledger. Whatever CVSI does next, these words stay.
CV Sciences, Inc. · CVSI · Distribution · $0.02
Recorded 2026-06-14 · before the outcome · scored mechanically